郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价N-(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels.

期刊:Molecular pharmacology发表年份:2024作者:Nicholas Denomme; Ciria C Hernandez; Hailey A Bock; Rachel F Ohana; Shreeya Bakshi; Alexander M Sherwood; John D McCorvy; Paul F Daley; Wyeth B Callaway; Jacob M Hull; Andrew Alt; Lori L Isom; Nicholas V Cozzi

药效评价Prolactin Mediates Long-Term, Seasonal Rheostatic Regulation of Body Mass in Female Mammals.

期刊:Endocrinology发表年份:2024作者:Christopher J Marshall; Alexandra Blake; Calum Stewart; T Adam Liddle; Irem Denizli; Fallon Cuthill; Neil P Evans; Tyler J Stevenson

药效评价Novel purification platform based on multimodal preparative scale separation of mAb fragments and aggregates.

期刊:Journal of chromatography. A发表年份:2024作者:Rashmi Sharma; Surbhi Gupta; Anurag S Rathore

药效评价Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor.

期刊:Journal of medicinal chemistry发表年份:2024作者:Xianglin Huang; Anna Chorianopoulou; Panagoula Kalkounou; Maria Georgiou; Athanasios Pousias; Amy Davies; Abigail Pearce; Matthew Harris; George Lambrinidis; Panagiotis Marakos; Nicole Pouli; Antonios Kolocouris; Nikolaos Lougiakis; Graham Ladds